MGC Pharmaceuticals to buy Australia’s top medicinal cannabis clinic

By Nikita Chaurasia  Date: 2020-07-20

MGC Pharmaceuticals to buy Australia’s top medicinal cannabis clinic

As reported by credible sources, MGC Pharmaceuticals Ltd, a European bio-pharma firm, aims to acquire the complete data, intellectual property, and operating clinic-based assets of Medicinal Cannabis Clinic Pty Ltd.

As per the agreement, the new company, which will be incorporated to hold all assets of MCC, will attain pertinent state and federal licenses. This permit will further enable the import and supply of medicinal cannabis products. The company would be able to offer inexpensive cannabinoid through the focused reduction of import, storage, and distribution costs per unit.

For those uninitiated, MGC Pharma specializes in production and development of medicines which are EU-GMP Phyto cannabinoid derived. It has signed an agreement with Cannvalate Pty Ltd in a bid to acquire its wholly owned subsidiary MCC, which s has an extensive network of patients and doctors.

Speaking of the move, co-founder & MD of MGC Pharma, said that the acquisition of MCC assets is a vital part of their strategy to expand their direct supply chain capabilities and distribution network in Australia, and world over. He further added that the organization will achieve its cashflow breakeven goals through this acquisition. The company looks forward to integrating high-quality clinics network of MCC, he said.

MGC Pharma has reportedly decided to continue services of MCC staff to maintain the continuity of operations of the new firm, ensuring exceptional clinical governance and independence. The fundamental business ethos, product offering, and existing operations of MCC will remain unchanged.

If reports are to be believed, the deal includes USD 400,000 in cash and USD 1 million in MGC Pharma shares. The clearance of the transaction is projected to be concluded within 90 days.

Source- https://www.proactiveinvestors.com.au/companies/news/924532/mgc-pharmaceuticals-moves-to-acquire-one-of-australia-s-leading-medicinal-cannabis-clinics-924532.html

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

CDC updates guidelines, calls for vaccinated people to mask up

CDC updates guidelines, calls for vaccinated people to mask up

By Nikita Chaurasia

The Centers for Disease Control and Prevention issued new guidelines suggesting that people who are vaccinated against Covid-19 wear masks in public as well as indoor areas where the rate of the disease is high. The CDC also stated that teachers, sta...

iPhone’s hot streak could be hampered by global chip shortage crisis

iPhone’s hot streak could be hampered by global chip shortage crisis

By Nikita Chaurasia

Apple Inc. recently stated that the global chip shortage that has affected the sales of Macs and iPads, will now hit iPhone production and the expected revenue growth is likely to decelerate. This has resulted in lowering Apple’s shares. The c...

EV maker Rivian bags USD 2.5 Bn in a funding round led by Amazon, Ford

EV maker Rivian bags USD 2.5 Bn in a funding round led by Amazon, Ford

By Nikita Chaurasia

American electric vehicle maker Rivian Automotive LLC reportedly secured USD 2.5 billion in a funding round led by Amazon.com Inc, T. Rowe Price, D1 Capital Partners, and Ford Motor Co. In addition, the event also saw participation from Fidelity Man...

ICEA forms committee chaired by HP India MD to boost IT hardware sector

ICEA forms committee chaired by HP India MD to boost IT hardware sector

By Nikita Chaurasia

The India Cellular & Electronics Association (ICEA) recently announced the formation of a committee to promote manufacturing and exports of the IT hardware sector. The panel headed by Ketan Patel, HP India’s Managing Director, will set up a...

Amazon to stop on-site COVID-19 testing in U.S. warehouses this month

Amazon to stop on-site COVID-19 testing in U.S. warehouses this month

By Nikita Chaurasia

Amazon is reportedly planning to discontinue on-site Coronavirus testing for its warehouse employees in the United States. The retail giant confirmed slowing down the testing by 30th July and will only resume after receiving new guidelines change fro...